Shintaro Kitayama

Associate, Brussels

Biography

Overview

Shintaro Kitayama is an associate in our Corporate/M&A practice group, based in Brussels. Mr. Kitayama has extensive experience in Corporate, M&A and antitrust matters.

Prior to joining White & Case, Mr. Kitayama worked at a leading law firm in Tokyo. He has also worked on secondment at leading Japanese automotive companies and a leading international bank.

During law school, he was a judicial intern for the Honorable Robert E. Grossman of the United States Bankruptcy Court for the Eastern District of New York. He also served as Articles & Notes Editor of the American Bankruptcy Institute Law Review.

Shintaro is recognized by Best Lawyers in its "Ones to Watch" category for Corporate and Mergers and Acquisitions Law in Japan.

Bars and Courts
New York
New Jersey State Bar
Brussels Bar (B list)
Education
JD
St. John's University School of Law
BS
St. John's University
Languages
Japanese
English

Experience

Toyota Motor Corporation in connection with its long-term collaborative projects with BMW AG, including the joint development of sports cars (BMW Z4 and Toyota Supra) and hydrogen fuel-cell vehicles.

Yamauchi-No.10 Family Office, the family office of the Yamauchi family which started and built up the global gaming giant Nintendo, in its acquisition of a majority stake in Taiyo Pacific Partners LP, which was founded in 2003 by Asia-focused professionals dedicated to friendly shareholder activism in Japan and India.

Yamauchi-No.10 Family Office in its proposed unsolicited counterbid to acquire Toyo Construction to privatise the Japanese construction company at an offer price of JPY 1,000 per share, or approximately 94 billion JPY in total.

Panasonic Corporation on its acquisition of the remaining 80% of the capital stock interests of Blue Yonder, a leading end-to-end, digital fulfillment platform provider, at an enterprise value of US$8.5 billion on a cash-free, debt-free basis. This transaction adds to the 20% stake of Blue Yonder which Panasonic Corporation acquired in July 2020, also represented by White & Case.

Panasonic Corporation on its 20% strategic equity investment in Blue Yonder, with an estimated enterprise value of US$5.5 billion

Mizuho Leasing Company, Limited., a Japanese general leasing company, in the US$160 million acquisition of 50% of the membership interest of PLM Fleet LLC, a U.S. refrigerated truck leasing and rental company.

IHI Corporation (IHI) on its equity investment and strategic partnership agreements with NuScale Power, LLC (NuScale), a leader in small modular reactor (SMR) nuclear technology. Investment is being made through a special-purpose investment vehicle jointly held by IHI and JGC.

Toyota Motor Corporation and its subsidiary Woven Planet Holdings, Inc. in a fleet of agreements related to the formation of a significant joint venture with Aisin, Denso and other parties for the development of the world's top-level software operating system for automated driving.

Toyota Motor Corporation in connection with the purchase by Toyota of all of its partner’s shares in Toyota Peugeot Citroën Automobile (TPCA), an auto manufacturing joint venture with the PSA Group (Peugeot Citroën). The PSA share of the joint venture has been purchased by Toyota, making TPCA a wholly owned subsidiary of Toyota Europe.

Canon Medical Systems Corporation, a Japanese medical equipment company, on its acquisition of Skope Magnetic Resonance Technologies AG, a Swiss company specializing in data processing and image reconstruction for magnetic resonance imaging (MRI).

IHI and its wholly-owned subsidiary IHI Agri-Tech Corporation (IAT) in the sale of IAT’s small-block diesel engine business to Caterpillar Inc. and its subsidiary Perkins Engines Company Limited.

Mitsui & Co., Ltd., a Japanese trading company, as the founder of and lead investor in Venchi Japan K.K., a joint venture company in Japan, with Venchi S.P.A., an Italian gourmet chocolate manufacturer.

NEC Corporation, a publicly traded Japanese IT services and product company, in connection with its series A strategic minority investment in BostonGene Corporation, a US biomedical software corporation.